Trials / Active Not Recruiting
Active Not RecruitingNCT06708715
Stress Reduction After Use of a Haptic Vibrotactile Trigger Technology Patch: Analysis and Assessment
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- SuperPatch Limited LLC · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to collect subject perceptions or feelings about their treatment. Participation includes a survey from individuals who are receiving a stress or anxiety-relieving topical patch \[Super Patch PEACE Patch with Haptic Vibrotactile Trigger Technology (VTT)\] and assigned to a Treatment Group or given a Sham patch, assigned to the Control Group, to address symptoms or stress and anxiety symptoms using validated scales \[for example, The Perceived Stress Scale (PSS) or Medical Outcomes Study Short Form-20 (SF-20)\].
Detailed description
This minimal risk observational study, will evaluate an over the counter (OTC) non-invasive, non- pharmacological patch (Super Patch PEACE Patch; The Super Patch Company Ltd LLC., SRYSTY Holding Co., Toronto, Canada) that is embedded with a proprietary sensory pattern and incorporates haptic vibrotactile trigger technology (VTT) and designed to trigger neural pathways and circuits associated with stress, anxiety, and other cortical networks, with other study participants who receive an 'inactive' (Sham) patch without the embedded VTT technology. The sensory patterns within the active patches are in close symmetry between known EEG patterns and their role in modulating EEG and neuronal circuits within higher brain centers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PEACE Patch | A topical patch that incorporates a sensory pattern of vibrotactile haptic technology. |
| DEVICE | Topical Sham Patch | Sham Patch that does not include vibrotactile haptic technology |
Timeline
- Start date
- 2023-05-05
- Primary completion
- 2026-05-01
- Completion
- 2026-05-01
- First posted
- 2024-11-27
- Last updated
- 2025-12-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06708715. Inclusion in this directory is not an endorsement.